Biopsy Devices Market Size, Share & Trends Analysis Report By Product Type (Needle Biopsy Devices (Guidance Systems, Biopsy Consoles, Site Markers, Biopsy Guns (Automated Systems, Semi-Automated Systems), Needles), Skin Biopsy Devices (Punch Biopsy Instruments, Shave Biopsy Instruments), Consumables (Forceps, Trocars, Trays, Other Consumables), By Biopsy Type, By Anatomy, By Disease Type, By Guidance Technique, By Region, And By Segment Forecasts, 2024-2031
Segmentation of Biopsy Devices Market-
Biopsy Devices Market By Product Type-
- Needle Biopsy Devices
- Guidance Systems
- Biopsy Consoles
- Site Markers
- Biopsy Guns
- Automated Systems
- Semi-Automated Systems
- Needles
- Skin Biopsy Devices
- Punch Biopsy Instruments
- Shave Biopsy Instruments
- Consumables
- Forceps
- Trocars
- Trays
- Other Consumables
Biopsy Devices Market By Biopsy Type
- Tissue Biopsy
- Needle Biopsy
- Surgical Biopsy
- Skin Biopsy
- Liquid Biopsy
Biopsy Devices Market By Anatomy-
- Breast
- Lung
- Bone
- Liver
- Uterus/Cervix/Ovary
- Abdomen
- Prostate
- Cardiac
- Skin
- Others
Biopsy Devices Market By Disease Type-
- Cancer
- Infections
- Autoimmune Disorders
- Non-Cancerous Indications
- Others
Biopsy Devices Market By Guidance Technique -
- Ultrasound-Guided Biopsy
- X-Ray-Guided Biopsy
- MRI-Guided Biopsy
- CT-Guided Biopsy
Biopsy Devices Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biopsy Devices Market Snapshot
Chapter 4. Global Biopsy Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:
5.2.1. Needle Biopsy Devices
5.2.1.1. Guidance Systems
5.2.1.2. Biopsy Consoles
5.2.1.3. Site Markers
5.2.1.4. Biopsy Guns
5.2.1.4.1. Automated Systems
5.2.1.4.2. Semi-Automated Systems
5.2.1.5. Needles
5.2.2. Skin Biopsy Devices
5.2.2.1. Punch Biopsy Instruments
5.2.2.2. Shave Biopsy Instruments
5.2.3. Consumables
5.2.3.1. Forceps
5.2.3.2. Trocars
5.2.3.3. Trays
5.2.3.4. Other Consumables
Chapter 6. Market Segmentation 2: By Biopsy Type Estimates & Trend Analysis
6.1. By Biopsy Type & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Biopsy Type:
6.2.1. Tissue Biopsy
6.2.1.1. Needle Biopsy
6.2.1.2. Skin Biopsy
6.2.1.3. Surgical Biopsy
6.2.2. Liquid Biopsy
Chapter 7. Market Segmentation 3: By Disease Type Estimates & Trend Analysis
7.1. By Disease Type & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Disease Type:
7.2.1. Cancer
7.2.2. Infections
7.2.3. Autoimmune Disorders
7.2.4. Non-Cancerous Indications
7.2.5. Others
Chapter 8. Market Segmentation 4: By Anatomy Estimates & Trend Analysis
8.1. By Anatomy & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Anatomy:
8.2.1. Breast
8.2.2. Lung
8.2.3. Bone
8.2.4. Liver
8.2.5. Uterus/Cervix/Ovary
8.2.6. Abdomen
8.2.7. Prostate
8.2.8. Cardiac
8.2.9. Skin
8.2.10. Others
Chapter 9. Market Segmentation 5: By Guidance Technique Estimates & Trend Analysis
9.1. By Guidance Technique & Market Share2019 2020 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Guidance Technique:
9.2.1. X-Ray-Guided Biopsy
9.2.2. Ultrasound-Guided Biopsy
9.2.3. MRI-Guided Biopsy
9.2.4. CT-Guided Biopsy
Chapter 10. Biopsy Devices Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Product, 2024-2031
10.1.2. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Biopsy Type, 2024-2031
10.1.3. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Disease Type, 2024-2031
10.1.4. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Anatomy, 2024-2031
10.1.5. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Guidance Technique, 2024-2031
10.1.6. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
10.2. Europe
10.2.1. Europe Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.2.2. Europe Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.2.3. Europe Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.2.4. Europe Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.2.5. Europe Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.2.6. Europe Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.3.2. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.3.3. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.3.4. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.3.5. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.3.6. Asia Pacific Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
10.4. Latin America
10.4.1. Latin America Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.4.2. Latin America Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.4.3. Latin America Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.4.4. Latin America Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.4.5. Latin America Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.4.6. Latin America Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.5.2. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.5.3. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.5.4. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.5.5. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.5.6. Middle East & Africa Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Argon Medical Devices, Inc.
11.2.2. B. Braun SE
11.2.3. Becton, Dickinson and Company
11.2.4. Boston Scientific Corporation
11.2.5. Cardinal Health, Inc.
11.2.6. Cook Group Incorporated
11.2.7. Conmed Corporation
11.2.8. FUJIFILM Holdings Corporation
11.2.9. GE Healthcare
11.2.10. Inrad, Inc.
11.2.11. Medtronic plc
11.2.12. Olympus Corporation
11.2.13. Siemens Healthineers AG
11.2.14. Stryker Corporation
11.2.15. Zamar Care
11.2.16. Changzhou Jiuhong Medical Instrument Co., Ltd.
11.2.17. Kindly (KDL) Meditech
11.2.18. Ningbo Xinwell Medical Technology Co., LTD.
11.2.19. Shenzhen Manners Technology Co., Ltd.
11.2.20. Zhejiang Soudon Medical Technology Co., Ltd
11.2.21. Agilent Technologies, Inc.
11.2.22. BGI Group
11.2.23. Biocept, Inc.
11.2.24. Bio-Rad Laboratories, Inc.
11.2.25. Dxcover Limited
11.2.26. Elypta Limited
11.2.27. F. Hoffmann-La Roche Ltd
11.2.28. Illumina, Inc.
11.2.29. Micronoma
11.2.30. QIAGEN
11.2.31. Revvity, Inc.
11.2.32. Sysmex Corporation
11.2.33. Thermo Fisher Scientific Inc.
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Biopsy Devices Market Size is valued at USD 6.84 Bn in 2023 and is predicted to reach USD 20.04 Bn by the year 2031
Biopsy Devices Market expected to grow at a 14.51% CAGR during the forecast period for 2024-2031.
F. Hoffmann-La Roche Ltd, Illumina, Inc., Micronoma, QIAGEN, Revvity, Inc., Sysmex Corporation, and Thermo Fisher Scientific Inc.